FSMAX
Price
$94.93
Change
-$0.10 (-0.11%)
Updated
Aug 5 closing price
Net Assets
39.63B
LVOPX
Price
$17.78
Change
-$0.03 (-0.17%)
Updated
Aug 5 closing price
Net Assets
1.12B
Interact to see
Advertisement

FSMAX vs LVOPX

Header iconFSMAX vs LVOPX Comparison
Open Charts FSMAX vs LVOPXBanner chart's image
Fidelity Extended Market Index
Price$94.93
Change-$0.10 (-0.11%)
VolumeN/A
Net Assets39.63B
Lord Abbett Value Opportunities P
Price$17.78
Change-$0.03 (-0.17%)
VolumeN/A
Net Assets1.12B
FSMAX vs LVOPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMAX vs. LVOPX commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and LVOPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 39.6B vs. LVOPX (1.12B). FSMAX pays higher dividends than LVOPX: FSMAX (0.46) vs LVOPX (0.00). FSMAX was incepted earlier than LVOPX: FSMAX (14 years) vs LVOPX (20 years). LVOPX (1.39) is less costly to investors than FSMAX (0.04). LVOPX is a more actively managed with annual turnover of: 33.00 vs. FSMAX (9.00). FSMAX (0) and LVOPX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 21.86 vs. LVOPX (-1.33). FSMAX return over 5 years is better than : 52.00 vs. LVOPX (7.81).
FSMAXLVOPXFSMAX / LVOPX
Total Expense Ratio0.041.393%
Annual Report Gross Expense Ratio0.041.393%
Fund Existence14 years20 years-
Gain YTD4.566-1.981-230%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets39.6B1.12B3,526%
Annual Yield % from dividends0.460.00-
Returns for 1 year21.86-1.33-1,644%
Returns for 3 years38.843.431,133%
Returns for 5 years52.007.81666%
Returns for 10 years84.21-10.63-792%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LE13.130.46
+3.63%
Lands' End
HALO60.810.82
+1.37%
Halozyme Therapeutics
CHSCP28.590.07
+0.23%
CHS
ICCC6.18-0.06
-0.96%
ImmuCell Corp
SRPT16.75-0.35
-2.05%
Sarepta Therapeutics